Group One Trading
PGEN icon

Group One Trading’s Precigen PGEN Stock Holding History

Group One Trading’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$77.8K Sell
20,100
-13,000
-39% -$53.3K ﹤0.01% 4940
2025
Q4 		$138K Sell
33,100
-83,300
-72% -$322K ﹤0.01% 4707
2025
Q3 		$383K Buy
116,400
+19,900
+21% +$56.2K ﹤0.01% 3957
2025
Q2 		$137K Buy
96,500
+96,000
+19,200% +$136K ﹤0.01% 4699
2025
Q1 		$745 Buy
+500
New +$787 ﹤0.01% 7226
2024
Q4 		– Sell
-2,300
Closed -$2.18K – 7803
2024
Q3 		$2.18K Hold
2,300
– – ﹤0.01% 6118
2024
Q2 		$3.63K Hold
2,300
– – ﹤0.01% 6073
2024
Q1 		$3.33K Buy
2,300
+700
+44% +$1K ﹤0.01% 6338
2023
Q4 		$2.14K Sell
1,600
-1,300
-45% -$1.53K ﹤0.01% 6800
2023
Q3 		$4.12K Sell
2,900
-4,800
-62% -$6.8K ﹤0.01% 6793
2023
Q2 		$8.86K Sell
7,700
-3,300
-30% -$3.9K ﹤0.01% 6459
2023
Q1 		$11.7K Sell
11,000
-41,900
-79% -$60.4K ﹤0.01% 5851
2022
Q4 		$80.4K Buy
52,900
+8,400
+19% +$14.4K ﹤0.01% 4630
2022
Q3 		$94K Sell
44,500
-7,100
-14% -$15K ﹤0.01% 4833
2022
Q2 		$69K Sell
51,600
-100
-0.2% -$148 ﹤0.01% 5300
2022
Q1 		$109K Sell
51,700
-231,900
-82% -$565K ﹤0.01% 5407
2021
Q4 		$1.05M Buy
283,600
+17,000
+6% +$73.2K ﹤0.01% 3308
2021
Q3 		$1.33M Sell
266,600
-28,400
-10% -$163K ﹤0.01% 3095
2021
Q2 		$1.92M Sell
295,000
-9,200
-3% -$64.3K ﹤0.01% 2696
2021
Q1 		$2.1M Buy
304,200
+250,400
+465% +$2.12M ﹤0.01% 2417
2020
Q4 		$549K Sell
53,800
-8,200
-13% -$53.2K ﹤0.01% 3182
2020
Q3 		$217K Buy
62,000
+10,600
+21% +$50.3K ﹤0.01% 3586
2020
Q2 		$256K Buy
51,400
+4,000
+8% +$13.6K ﹤0.01% 3181
2020
Q1 		$161K Sell
47,400
-195,000
-80% -$841K ﹤0.01% 2927
2019
Q4 		$1.33M Sell
242,400
-64,500
-21% -$363K 0.01% 1634
2019
Q3 		$1.75M Buy
306,900
+189,900
+162% +$1.29M 0.01% 1315
2019
Q2 		$896K Buy
117,000
+42,600
+57% +$229K 0.01% 1674
2019
Q1 		$391K Buy
74,400
+34,500
+86% +$239K ﹤0.01% 2151
2018
Q4 		$261K Buy
39,900
+5,800
+17% +$65K ﹤0.01% 2478
2018
Q3 		$587K Sell
34,100
-19,800
-37% -$294K ﹤0.01% 2150
2018
Q2 		$751K Buy
53,900
+17,600
+48% +$297K 0.01% 1968
2018
Q1 		$556K Sell
36,300
-133,700
-79% -$1.91M 0.01% 1975
2017
Q4 		$1.96M Buy
170,000
+22,700
+15% +$338K 0.01% 1195
2017
Q3 		$2.8M Buy
147,300
+12,600
+9% +$259K 0.03% 849
2017
Q2 		$3.25M Buy
134,700
+12,500
+10% +$274K 0.03% 669
2017
Q1 		$2.42M Sell
122,200
-57,806
-32% -$1.29M 0.03% 747
2016
Q4 		$4.33M Buy
180,006
+31,481
+21% +$876K 0.04% 496
2016
Q3 		$4.13M Buy
148,525
+38,039
+34% +$1.01M 0.04% 495
2016
Q2 		$2.69M Buy
110,486
+81,124
+276% +$2.3M 0.03% 651
2016
Q1 		$986K Sell
29,362
-63,769
-68% -$2.01M 0.01% 1182
2015
Q4 		$2.78M Sell
93,131
-32,994
-26% -$1.11M 0.03% 651
2015
Q3 		$3.98M Sell
126,125
-56,302
-31% -$2.75M 0.06% 425
2015
Q2 		$8.82M Sell
182,427
-104,059
-36% -$4.39M 0.12% 174
2015
Q1 		$12.4M Buy
286,486
+156,008
+120% +$5.61M 0.2% 78
2014
Q4 		$3.43M Buy
130,478
+4,813
+4% +$106K 0.05% 409
2014
Q3 		$2.23M Sell
125,665
-1,988
-2% -$40.6K 0.03% 624
2014
Q2 		$3.07M Buy
127,653
+99,402
+352% +$2.02M 0.05% 486
2014
Q1 		$710K Buy
28,251
+14,544
+106% +$403K 0.01% 1360
2013
Q4 		$312K Sell
13,707
-10,777
-44% -$218K ﹤0.01% 2037
2013
Q3 		$554K Buy
+24,484
New +$565K 0.01% 1528

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Group One Trading's PGEN Position: Q1 2026 in Review

Group One Trading reduced its Precigen (PGEN) stake by 14% in Q1 2026, selling an estimated $120K and leaving 179,123 shares worth $693K. The position accounts for ﹤0.01% of the portfolio, ranked #3033.

Group One Trading first reported a position in PGEN in Q3 2013 and has held it in 34 quarters since. The position peaked at $3.17M in Q2 2015. 205 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

  • Group One Trading held 179,123 shares of Precigen worth $693K as of Q1 2026.
  • Group One Trading sold 29,322 Precigen shares in Q1 2026, an estimated $120K.
  • Precigen made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3033 holding.
  • Group One Trading first reported a position in Precigen in Q3 2013 and has held it in 34 quarters since.
  • Group One Trading's Precigen position peaked at $3.17M in Q2 2015.
  • 205 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.